Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
November 26 2007 - 1:29PM
PR Newswire (US)
WELLESLEY, Mass., Nov. 26 /PRNewswire-FirstCall/ -- Coley
Pharmaceutical Group, Inc. (NASDAQ:COLY), today announced that
Robert L. Bratzler, Ph.D., President & Chief Executive Officer,
will be presenting a corporate update at the upcoming Lazard
Capital Markets Fourth Annual Healthcare Conference at 10:00am ET
on November 27th, 2007 at the New York Palace Hotel. Interested
parties may access an audio webcast of the presentation by visiting
the Coley Pharmaceutical Group website at
http://www.coleypharma.com/. A replay of the webcast will be
archived on the "Investor Events" page in the Investor Center
section of the Coley website for two weeks until December 11th,
2007. About Coley Pharmaceutical Group Coley Pharmaceutical Group,
Inc. is an international biopharmaceutical company, headquartered
in Wellesley, Massachusetts, USA, that discovers and develops TLR
Therapeutics(TM), a new class of investigational drug candidates
that direct the human immune system to fight cancers, autoimmune
diseases, allergy and asthma disorders and to enhance the
effectiveness of vaccines. Coley has established a pipeline of TLR
Therapeutic product candidates currently advancing through clinical
development with partners and has additional product candidates in
preclinical development. Coley has product development, research
and license agreements with Pfizer, sanofi-aventis,
GlaxoSmithKline, Merck, Novartis Vaccines and the United States
government. The company recently announced that it has entered into
an agreement to be acquired by Pfizer Inc through a cash tender
offer at a price of $8.00 per share. For further information on
Coley Pharmaceutical Group please visit
http://www.coleypharma.com/. DATASOURCE: Coley Pharmaceutical Group
CONTACT: Susan Hager, Sr. Director, Investor Relations and
Corporate Communications, of Coley Pharmaceutical Group,
+1-781-431-9079, ; Karen L. Bergman, +1-605-575-1509, , or Michelle
Corral, +1-415-794-8662, , both of BCC Partners, for Coley
Pharmaceutical Group Web site: http://www.coleypharma.com/
Copyright
Coley Pharmaceutical Grp. (MM) (NASDAQ:COLY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Coley Pharmaceutical Grp. (MM) (NASDAQ:COLY)
Historical Stock Chart
From Aug 2023 to Aug 2024